Cargando…

Short-Term Treatment with Esmolol Reverses Left Ventricular Hypertrophy in Adult Spontaneously Hypertensive Rats via Inhibition of Akt/NF-κB and NFATc4

Our group has previously demonstrated that short-term treatment with esmolol reduces left ventricular hypertrophy (LVH) in spontaneously hypertensive rats (SHRs). The present study aimed to assess the molecular mechanisms related to this effect. Fourteen-month-old male SHR(s) were treated intravenou...

Descripción completa

Detalles Bibliográficos
Autores principales:	Quintana-Villamandos, Begoña, Goukassian, David A., Sasi, Sharath P., Delgado-Baeza, Emilio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5835291/ https://www.ncbi.nlm.nih.gov/pubmed/29670896 http://dx.doi.org/10.1155/2018/2691014

Ejemplares similares

Inhibition of the NFATc4/ERK/AKT Pathway and Improvement of Thiol-Specific Oxidative Stress by Dronedarone Possibly Secondary to the Reduction of Blood Pressure in an Animal Model of Ventricular Hypertrophy
por: Pazó-Sayós, Laia, et al.
Publicado: (2020)

Short-Term Esmolol Improves Coronary Artery Remodeling in Spontaneously Hypertensive Rats through Increased Nitric Oxide Bioavailability and Superoxide Dismutase Activity
por: Arnalich-Montiel, Ana, et al.
Publicado: (2014)

Plasma protein thiolation index (PTI) as a potential biomarker for left ventricular hypertrophy in humans
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2019)

Impact of a Multichannel Blocker in Attenuating Intramyocardial Artery Remodeling in Hypertensive Rats through Increased Nitric Oxide Bioavailability
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2019)

Effects of Sevoflurane and Propofol on Organ Blood Flow in Left Ventricular Assist Devices in Pigs
por: Morillas-Sendín, Paloma, et al.
Publicado: (2015)

Corrigendum to “Effects of Sevoflurane and Propofol on Organ Blood Flow in Left Ventricular Assist Devices in Pigs”
por: Morillas-Sendín, Paloma, et al.
Publicado: (2016)

Maintenance over Time of the Effect Produced by Esmolol on the Structure and Function of Coronary Arteries in Hypertensive Heart Diseases
por: Martín-Oropesa, Raquel, et al.
Publicado: (2022)

OXY-SCORE: a new perspective for left ventricular hypertrophy diagnosis
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2020)

Feasibility of prehospital esmolol for refractory ventricular fibrillation
por: Patrick, Casey, et al.
Publicado: (2022)

Esmolol for intractable ventricular arrhythmias in major amitriptyline toxicity
por: Garrett, Peter, et al.
Publicado: (2022)

Esmolol Use in Dual Axis Defibrillation Resistant Ventricular Fibrillation
por: Agrawal, Ankit, et al.
Publicado: (2020)

Isofraxidin Inhibits Receptor Activator of Nuclear Factor-κB Ligand–Induced Osteoclastogenesis in Bone Marrow–Derived Macrophages Isolated from Sprague–Dawley Rats by Regulating NF-κB/NFATc1 and Akt/NFATc1 Signaling Pathways
por: Wang, Wei, et al.
Publicado: (2021)

SIRT6 Suppresses NFATc4 Expression and Activation in Cardiomyocyte Hypertrophy
por: Li, Zhenzhen, et al.
Publicado: (2019)

The influence of esmolol on right ventricular function in early experimental endotoxic shock
por: van Loon, Lex M., et al.
Publicado: (2018)

Dronedarone produces early regression of myocardial remodelling in structural heart disease
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2017)

Tusc2/Fus1 regulates osteoclast differentiation through NF-κB and NFATc1
por: Kim, Inyoung, et al.
Publicado: (2017)

The antinociceptive effect of esmolol
por: Kim, Yoon Hee
Publicado: (2010)

The protective effect of dronedarone on the structure and mechanical properties of the aorta in hypertensive rats by decreasing the concentration of symmetric dimethylarginine (SDMA)
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2019)

TNF-α and IL-1α but not MCP-1 and Rantes increase significantly the formation of p-H2AX foci in naïve BM-derived TNFR1/p55KO EPCs
por: Sasi, Sharath P., et al.
Publicado: (2014)

Peiminine Suppresses RANKL-Induced Osteoclastogenesis by Inhibiting the NFATc1, ERK, and NF-κB Signaling Pathways
por: Zhu, Mengbo, et al.
Publicado: (2021)

Cardiac output monitoring with pulmonary versus trans-cardiopulmonary thermodilution in left ventricular assist devices: Interchangeable methods?
por: Quintana-Villamandos, Begoña, et al.
Publicado: (2022)

KMUP-1 Suppresses RANKL-Induced Osteoclastogenesis and Prevents Ovariectomy-Induced Bone Loss: Roles of MAPKs, Akt, NF-κB and Calcium/Calcineurin/NFATc1 Pathways
por: Liou, Shu-Fen, et al.
Publicado: (2013)

Diallyl disulfide alleviates inflammatory osteolysis by suppressing osteoclastogenesis via NF-κB–NFATc1 signal pathway
por: Yang, Jing, et al.
Publicado: (2019)

Aspirin inhibits RANKL-induced osteoclast differentiation in dendritic cells by suppressing NF-κB and NFATc1 activation
por: Wu, Lili, et al.
Publicado: (2019)

Maackiain dampens osteoclastogenesis via attenuating RANKL‐stimulated NF‐κB signalling pathway and NFATc1 activity
por: Liu, Yuhao, et al.
Publicado: (2020)

IRF2 enhances RANKL-induced osteoclast differentiation via regulating NF-κB/NFATc1 signaling
por: Kim, Inyoung, et al.
Publicado: (2021)

Radiation-associated degenerative cardiovascular risks during normal aging and after adverse CV event 10 months post-initial exposure
por: Sasi, Sharath P., et al.
Publicado: (2014)

Monotropein Protects against Inflammatory Bone Loss and Suppresses Osteoclast Formation and Bone Resorption by Inhibiting NFATc1 via NF-κB and Akt/GSK-3β Pathway
por: Zhang, Qi, et al.
Publicado: (2022)

Slower Growth during Lactation Rescues Early Cardiovascular and Adipose Tissue Hypertrophy Induced by Fetal Undernutrition in Rats
por: Rodríguez-Rodríguez, Pilar, et al.
Publicado: (2022)

Tanshinone IIA Protects Against Cardiac Hypertrophy via Inhibiting Calcineurin/Nfatc3 Pathway
por: Tan, Xueying, et al.
Publicado: (2011)

Spironolactone Inhibits Cardiomyocyte Hypertrophy by Regulating the Ca(2+)/Calcineurin/p-NFATc3 Pathway
por: Wang, Xin, et al.
Publicado: (2021)

Agelasine D Suppresses RANKL-Induced Osteoclastogenesis via Down-Regulation of c-Fos, NFATc1 and NF-κB
por: Kang, Moo Rim, et al.
Publicado: (2014)

First Report of Survival in Refractory Ventricular Fibrillation After Dual-Axis Defibrillation and Esmolol Administration
por: Boehm, Kevin M., et al.
Publicado: (2016)

The Evolving Role of Esmolol in Management of Pre-Hospital Refractory Ventricular Fibrillation; a Scoping Review
por: Miraglia, Dennis, et al.
Publicado: (2020)

MIP-1δ Activates NFATc1 and Enhances Osteoclastogenesis: Involvement of Both PLCγ2 and NFκB Signaling
por: Weber, Kristy L., et al.
Publicado: (2012)

Betulinic Acid Improves Cardiac-Renal Dysfunction Caused by Hypertrophy through Calcineurin-NFATc3 Signaling
por: Hong, Mi-Hyeon, et al.
Publicado: (2021)

Indicators of haemodynamic instability and left ventricular function in a porcine model of esmolol induced negative inotropy
por: Davies, Simon, et al.
Publicado: (2022)

NFATC1 and NFATC2 expression patterns in human osteochondromas
por: Wang, Yuanyuan, et al.
Publicado: (2023)

Dobutamine Alters the Pharmacokinetic and Pharmacodynamic Behavior of Esmolol
por: Krumpl, Günther, et al.
Publicado: (2020)

Esmolol Is Not the Solution: Thyroid Storm With Atrial Fibrillation
por: Herzallah, Zaid N, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_2le033iiu8vivi9v3u4p3nfvsf